J&J-GUIDANT MERGER TO SHAKE UP STENT MARKET

Healthcare giant Johnson & Johnson recently agreed to buy heart-device maker Guidant for $21.5 billion, ending a month of uncertainty about the deal and creating a new competitive landscape for Boston Scientific, the largest life-sciences company in Massachusetts.
Boston Globe